On Demand
The multiple sclerosis (MS) and neuroimmunology field enjoyed a recent explosion of effective therapeutic options that are used to manage patients with this chronic and previously frequently disabling condition. While there is no cure for MS, disease modifying treatments (DMTs) reduce clinical and radiographic disease activity and delay MS progression to neurologic disability. However, with the increase in therapeutic options comes complexity of choices, and a true opportunity to practice personalized medicine, selecting the most appropriate, effective, and safe treatment choice for the patients. The need to initiate, stop or change DMTs depends on patients’ previous treatments, disease stability or progression, family planning needs, age, gender, and availability of therapies within their health insurance coverage. Special populations, such as children, older adults, and women in the reproductive planning phases of their lives have additional treatment considerations. Managing MS symptoms is important aspect of comprehensive MS care, as is non-pharmacologic approach to rehabilitation improvement of the overall quality of life. The research efforts in basic and clinical neuroimmunology have expanded our understanding of MS pathogenesis. Recent important contributions have focused on the effects of genetic predisposition and the microbiota on disease onset and progression, and the novel neuroimaging techniques and biomarker predictors of disease outcomes.
This CME program accredited by Harvard Medical School will present the most up-to-date clinical and research information relevant to health care providers who treat patients with multiple sclerosis. Through this initiative, participants will advance their knowledge and competence to provide excellent clinical care to patients with MS and will thoroughly improve their understanding of the recent and important research trends and results in this rapidly developing field.
t clinical care to patients with MS and will thoroughly improve their understanding of the recent and important research trends and results in this rapidly developing field.
Please contact the Continuing Education Programs with any questions by email at learn@hms.harvard.edu.
